{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T11:05:41Z","timestamp":1792062341979,"version":"4.4.0"},"reference-count":116,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2000,3,1]],"date-time":"2000-03-01T00:00:00Z","timestamp":951868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2000,3]]},"DOI":"10.1054\/blre.1999.0123","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T11:33:30Z","timestamp":1027683210000},"page":"44-61","source":"Crossref","is-referenced-by-count":236,"title":["RhD haemolytic disease of the fetus and the newborn"],"prefix":"10.1054","volume":"14","author":[{"given":"S.J.","family":"Urbaniak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Greiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1054\/blre.1999.0123_RF1","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0887-7963(88)70039-5","article-title":"The prevention of Rh immunization","volume":"2","author":"Bowman","year":"1988","journal-title":"Trans Med Rev"},{"key":"10.1054\/blre.1999.0123_RF2","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0022-3476(32)80057-0","article-title":"Erythroblastosis fetalis and its association with universal edema of the fetus, icterus gravis neonatorum and anemia of the newborn","volume":"1","author":"Diamond","year":"1932","journal-title":"J Pediatr"},{"key":"10.1054\/blre.1999.0123_RF3","first-page":"155","article-title":"A contribution to the study of erythroblastosis: icterus gravis neonatorum","volume":"3","author":"Hawksley","year":"1934","journal-title":"Quart J Med"},{"key":"10.1054\/blre.1999.0123_RF4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/adc.19.97.1","article-title":"Erythroblastosis fetalis","volume":"19","author":"Gilmour","year":"1944","journal-title":"Arch Dis Child"},{"key":"10.1054\/blre.1999.0123_RF5","first-page":"378","article-title":"Icterus gravis (erythroblastosis neonatorum, examination of etiologic considerations)","volume":"25","author":"Darrow","year":"1938","journal-title":"Arch Pathol"},{"key":"10.1054\/blre.1999.0123_RF6","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1001\/jama.1939.72800270002007a","article-title":"An unusual case of intra-group agglutination","volume":"113","author":"Levine","year":"1939","journal-title":"J Amer Med Ass"},{"key":"10.1054\/blre.1999.0123_RF7","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3181\/00379727-43-11151","article-title":"An agglutinable factor in human blood recognized by immune sera for rhesus blood","volume":"43","author":"Landsteiner","year":"1940","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1054\/blre.1999.0123_RF8","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/S0140-6736(54)92446-0","article-title":"Anemia from bleeding of the fetus into the mother\u2019s circulation","volume":"1","author":"Chown","year":"1954","journal-title":"Lancet"},{"key":"10.1054\/blre.1999.0123_RF9","first-page":"904","volume":"2","year":"1966","journal-title":"BMJ"},{"key":"10.1054\/blre.1999.0123_RF10","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1537-2995.1968.tb04895.x","article-title":"Results of clinical trials of RhoGAM in women","volume":"8","author":"Pollack","year":"1968","journal-title":"Transfusion"},{"key":"10.1054\/blre.1999.0123_RF11","first-page":"468","year":"1971","journal-title":"Technical Report Series"},{"key":"10.1054\/blre.1999.0123_RF12","unstructured":"Proceedings of the Joint Royal College of Physicians of Edinburgh and the Royal College of Obstetricians and Gynaecologists Consensus Conference on Anti-D Prophylaxis. Urbaniak, S. J, Br J Obstet Gynaecol, 1998, 105 suppl 18."},{"key":"10.1054\/blre.1999.0123_RF13","article-title":"Scientific Basis of Transfusion Medicine","author":"Anderson","year":"2000","journal-title":"Implication for Clinical Practice"},{"key":"10.1054\/blre.1999.0123_RF14","doi-asserted-by":"crossref","unstructured":"Garratty, G. Immunobiology of Transfusion Medicine. Marcel Dekker, 1994","DOI":"10.1201\/9781482293494"},{"key":"10.1054\/blre.1999.0123_RF15","series-title":"Applied Blood Group Serology.","author":"Issitt","year":"1998"},{"key":"10.1054\/blre.1999.0123_RF16","first-page":"1","article-title":"The management of Rh-isoimmunisation","volume":"52","author":"Bowman","year":"1978","journal-title":"J Obstet Gynaecol"},{"key":"10.1054\/blre.1999.0123_RF17","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0887-7963(90)70265-9","article-title":"Treatment options for the fetus with alloimmune hemolytic disease","volume":"4","author":"Bowman","year":"1990","journal-title":"Trans Med Rev"},{"key":"10.1054\/blre.1999.0123_RF18","unstructured":"Mollison, P. L. Engelfriet, C. P. Contreras, M. Blood Transfusion in Clinical Medicine, 10th ed, Chapters 3, 5, 12. Oxford, Blackwell Scientific Publications, 1997"},{"key":"10.1054\/blre.1999.0123_RF19","first-page":"61","article-title":"Rhesus disease in this decade","volume":"6","author":"Murphy","year":"1994","journal-title":"obstetrics. Contemp. Rev. Obstet. Gynaecol"},{"key":"10.1054\/blre.1999.0123_RF20","series-title":"Blood Transfusion: The Impact of New Technologies. Bailliere\u2019s Clinical Haematology Series,","first-page":"289","article-title":"New Approach in the Treatment of Haemolytic Disease of the Fetus","author":"Tannirandorn","year":"1990"},{"key":"10.1054\/blre.1999.0123_RF21","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/0002-9378(78)90270-3","article-title":"Intrauterine fetal transfusion, 1965\u20131976, with an assessment of the surviving children","volume":"130","author":"White","year":"1978","journal-title":"Am J Obstet Gynecol"},{"key":"10.1054\/blre.1999.0123_RF22","unstructured":"Stites, D. P. Tern, A. I. Parslow, T. G. Basic & Clinical Immunology 8th ed. A LANGE Medical Book."},{"key":"10.1054\/blre.1999.0123_RF23","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1182\/blood.V36.3.310.310","article-title":"Hematological observation on anaemia associated with blood type Rhnull","volume":"36","author":"Sturgeon","year":"1970","journal-title":"Blood"},{"key":"10.1054\/blre.1999.0123_RF24","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1182\/blood.V48.3.457.457","article-title":"Increased potassium transport and ollabain binding in human Rhnullred blood cells","volume":"48","author":"Lauf","year":"1976","journal-title":"Blood"},{"key":"10.1054\/blre.1999.0123_RF25","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1042\/bj2210931","article-title":"Rhnullhuman erythrocytes have an abnormal member phospholipid organisation","volume":"221","author":"Kuypers","year":"1984","journal-title":"Biochem J"},{"key":"10.1054\/blre.1999.0123_RF26","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1182\/blood.V95.1.12","article-title":"The presence of an RHD pseudogene containing a 37 base pair duplication and a nonsense muatation in Africans with the RhD-negative blood group phenotype","volume":"95","author":"Singleton","year":"2000","journal-title":"Blood"},{"key":"10.1054\/blre.1999.0123_RF27","first-page":"459","article-title":"A model for RhD \u2013 the relationship of 30 serologically defined epitopes to predicted structure","volume":"5","author":"Scott","year":"1997","journal-title":"Biotest Bulletin"},{"key":"10.1054\/blre.1999.0123_RF28","unstructured":"Daniels, G. Lomas-Francis, C. Wallace, M. Epitopes of RhD: Serology and Molecular Genetics. Molecular and Functional Aspects of Blood Groups Antigens. Silberstein, L. E. American Association of Blood Banks, Bethesda, Maryland, 1995, 193, 228"},{"key":"10.1054\/blre.1999.0123_RF29","unstructured":"Vengelen-Tyler, V. Technical Manual, American Association of Blood Banks, 1999"},{"key":"10.1054\/blre.1999.0123_RF30","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1182\/blood.V95.2.375","article-title":"The Rh group system: a review","volume":"95","author":"Avent","year":"2000","journal-title":"Blood"},{"key":"10.1054\/blre.1999.0123_RF31","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1182\/blood.V93.1.385","article-title":"Molecular basis of weak D phenotypes","volume":"93","author":"Wagner","year":"1999","journal-title":"Blood"},{"key":"10.1054\/blre.1999.0123_RF32","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1046\/j.1365-3148.1999.009001093.x","article-title":"Recommendations for the use of anti-D immunoglobulin for Rh prophylaxis","volume":"9","author":"Lee","year":"1999","journal-title":"Transfusion Medicine"},{"key":"10.1054\/blre.1999.0123_RF33","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1537-2995.1971.tb04424.x","article-title":"Studies on Rh prophylaxis. 1. Relationship between doses of anti-Rh and size of antigenic stimulus","volume":"11","author":"Pollack","year":"1971","journal-title":"Transfusion"},{"key":"10.1054\/blre.1999.0123_RF34","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1046\/j.1537-2995.1981.21181127486.x","article-title":"A successful programme of immunising Rh-negative male volunteers for anti-D production using thawed blood","volume":"21","author":"Urbaniak","year":"1981","journal-title":"Transfusion"},{"key":"10.1054\/blre.1999.0123_RF35","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1423-0410.1972.tb03475.x","article-title":"Immunisation of Rh-negative volunteers by repeated injection of very small amounts of Rh-positive blood","volume":"23","author":"Jakobowicz","year":"1972","journal-title":"Vox Sang"},{"key":"10.1054\/blre.1999.0123_RF36","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1365-3148.1994.tb00245.x","article-title":"Guideline for administration of Blood products: transfusion of infants and neonates","volume":"4","author":"Voak","year":"1994","journal-title":"Transfusion Medicine"},{"key":"10.1054\/blre.1999.0123_RF37","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1365-3148.1996.tb00079.x","article-title":"Guideline for pre-transfusion compatibility procedures in blood transfusion laboratories","volume":"6","author":"Napier","year":"1996","journal-title":"Transfusion Medicine"},{"key":"10.1054\/blre.1999.0123_RF38","first-page":"1S","article-title":"The identification of peptides which stimulate helper T-cells in vitro","volume":"39","author":"Urbaniak","year":"1999","journal-title":"Transfusion"},{"key":"10.1054\/blre.1999.0123_RF39","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1423-0410.1986.tb00226.x","article-title":"Fetomaternal transplacental hemorrhage during pregnancy and after delivery","volume":"51","author":"Bowman","year":"1986","journal-title":"Vox Sang"},{"key":"10.1054\/blre.1999.0123_RF40","unstructured":"Hann, I. M. Gibson, B. E. S. Letsky, E. A. Fetal and Neonatal Haematology (Chapters 5 & 7). Bailliere Tindall, 1991"},{"key":"10.1054\/blre.1999.0123_RF41","unstructured":"Quinley, E. D. Immunohaematology: Principles and Practice. J B Lippincott Company, 1993"},{"key":"10.1054\/blre.1999.0123_RF42","series-title":"Blood Transfusion: The Impact of New Technologies, Bailliere\u2019s Clinical Haematology Series,","first-page":"321","article-title":"ADCC and Other Cellular Bioassays for Predicting the Clinical Significance of Red Cell Alloantibodies","author":"Engelfriet","year":"1990"},{"key":"10.1054\/blre.1999.0123_RF43","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1365-2141.1979.tb01135.x","article-title":"ADCC (K-cell) lysis of human erythrocytes sensitized with rhesus antibodies II. Investigation into mechanism of lysis","volume":"42","author":"Urbaniak","year":"1979","journal-title":"Br J Haematol"},{"key":"10.1054\/blre.1999.0123_RF44","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1365-2141.1980.tb05992.x","article-title":"ADCC (K-cell) lysis of human erythrocytes sensitised with rhesus antibodies III. Comparison of IgG anti-D agglutinating and lytic (ADCC) activity and the role of IgG subclasses","volume":"46","author":"Urbaniak","year":"1980","journal-title":"Br J Haematol"},{"key":"10.1054\/blre.1999.0123_RF45","series-title":"Robbins Pathologic Basis of Disease. Chapter 11","article-title":"Diseases of Infancy and Childhood","author":"Schofield","year":"1999"},{"key":"10.1054\/blre.1999.0123_RF46","unstructured":"Mollison, P. L. Blood transfusion in clinical medicine, 1961, 614"},{"key":"10.1054\/blre.1999.0123_RF47","series-title":"Haemolytic Anaemia, 3rd.","article-title":"Haemolytic disease of the newborn","author":"Dacie","year":"1999"},{"key":"10.1054\/blre.1999.0123_RF48","series-title":"Hematologic problems in the newborn.","first-page":"283","article-title":"Erythroblastosis fetalis","author":"Naiman","year":"1982"},{"key":"10.1054\/blre.1999.0123_RF49","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0022-3476(89)80709-7","article-title":"Neutropenia and thrombocytopenia in infants with Rh hemolytic disease","volume":"114","author":"Koenig","year":"1989","journal-title":"J Pediatr"},{"key":"10.1054\/blre.1999.0123_RF50","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0022-3476(89)80092-7","article-title":"Late hyporegenerative anemia in Rh hemolytic disease","volume":"115","author":"Koenig","year":"1989","journal-title":"J Pediatr"},{"key":"10.1054\/blre.1999.0123_RF51","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0002-9378(91)90228-J","article-title":"Hyporegenerative anemia associated with intrauterine transfusion in rhesus hemolytic disease","volume":"165","author":"Thorp","year":"1991","journal-title":"Am J Obstet Gynecol"},{"key":"10.1054\/blre.1999.0123_RF52","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1542\/peds.90.5.678","article-title":"Recombinant erythropoietin as treatment for the late hyporegenerative anemia of Rh hemolytic disease","volume":"90","author":"Ohls","year":"1992","journal-title":"Pediatrics"},{"key":"10.1054\/blre.1999.0123_RF53","series-title":"Hematologic problems of the neonate.","first-page":"185","article-title":"Evaluation and treatment of erythroblastosis fetalis in the neonate","author":"Koenig","year":"2000"},{"key":"10.1054\/blre.1999.0123_RF54","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S0022-3476(79)80236-X","article-title":"The quantification of spherocytes in ABO hemolytic disease","volume":"94","author":"Zipursky","year":"1979","journal-title":"J Pediatr"},{"key":"10.1054\/blre.1999.0123_RF55","series-title":"Hematology of infancy and childhood.","first-page":"53","article-title":"Immune hemolytic disease","author":"Bowman","year":"1997"},{"key":"10.1054\/blre.1999.0123_RF56","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1136\/adc.38.197.54","article-title":"Obstructive jaundice and haemolytic disease of the newborn","volume":"38","author":"Dunn","year":"1963","journal-title":"Arch Dis Child,"},{"key":"10.1054\/blre.1999.0123_RF57","first-page":"13","article-title":"Cardiorespiratory status of erythroblastotic newborn infants","volume":"53","author":"Phibbs","year":"1974","journal-title":"II. Blood volume, hematocrit, and serum albumin concentration in relation to hydrops fetalis. Pediatrics"},{"key":"10.1054\/blre.1999.0123_RF58","series-title":"Neurology of the newborn.","first-page":"386","article-title":"Bilirubin and brain injury","author":"Volpe","year":"1987"},{"key":"10.1054\/blre.1999.0123_RF59","first-page":"574","article-title":"Conjugated serum bilirubin in erythroblastosis fetalis: an analysis of 38 cases","volume":"37","author":"Harris","year":"1962","journal-title":"Mayo Clin Proc"},{"key":"10.1054\/blre.1999.0123_RF60","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1172\/JCI104891","article-title":"Bilirubin metabolism in the fetus","volume":"43","author":"Shenker","year":"1964","journal-title":"J Clin Invest"},{"key":"10.1054\/blre.1999.0123_RF61","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1423-0410.1991.tb00944.x","article-title":"High does intravenous IgG for the treatment of severe rhesus alloimmunisation","volume":"61","author":"Margulies","year":"1991","journal-title":"Vox Sang"},{"key":"10.1054\/blre.1999.0123_RF62","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1046\/j.1365-2141.1997.8762507.x","article-title":"Transfer of anti-D antibodies across the isolated perfused human lobule and inhibition by high dose intravenous immunoglobulin: a possible mechanism of action","volume":"96","author":"Urbaniak","year":"1997","journal-title":"Br J Haematol,"},{"key":"10.1054\/blre.1999.0123_RF63","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1515\/jpme.1995.23.6.443","article-title":"Neonatal administration of high-dose intravenous immunoglobulin in rhesus hemolytic diease","volume":"23","author":"Voto","year":"1995","journal-title":"J Perinat Med"},{"key":"10.1054\/blre.1999.0123_RF64","first-page":"421","article-title":"Changing trends in the management of red blood cell alloimmunization in pregnancy","volume":"118","author":"Moise","year":"1994","journal-title":"Arch Pathol Lab Med"},{"key":"10.1054\/blre.1999.0123_RF65","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1046\/j.1365-3148.1996.d01-518.x","article-title":"Guidelines for blood grouping and red cell antibody testing during pregnancy","volume":"6","author":"Voak","year":"1996","journal-title":"Transfusion Medicine"},{"key":"10.1054\/blre.1999.0123_RF66","unstructured":"Sebring, E. S. Fetomaternal Hemorrhage \u2013 Incidence and Method of Detection and Quantitation. Hemolytic Disease of the Newborn. G. Garratty, American Association of Blood Banks, 1984, 87, 117"},{"key":"10.1054\/blre.1999.0123_RF67","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0002-9378(12)91132-1","article-title":"The use of Kleihauer-Betke stain in pregnant patients with abdominal trauma","volume":"168","author":"Van den Veyver","year":"1993","journal-title":"Am J Obstet Gynecol."},{"key":"10.1054\/blre.1999.0123_RF68","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1046\/j.1365-3148.1999.009001087.x","article-title":"The estimation of fetomaternal haemorrhage","volume":"9","author":"Kelsey","year":"1999","journal-title":"Transfusion Medicine"},{"key":"10.1054\/blre.1999.0123_RF69","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1046\/j.1365-2141.1999.01618.x","article-title":"A prospective study of routine antenatal enzyme antibody screening demonstrates lack of clinical value in predicting haemolytic disease of the newborn","volume":"106","author":"Clark","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1054\/blre.1999.0123_RF70","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1046\/j.1365-3148.1999.009001099.x","article-title":"Addendum for guidelines for blood grouping and red cell antibody testing during pregnancy","volume":"9","author":"Bruce","year":"1999","journal-title":"Transfusion Medicine"},{"key":"10.1054\/blre.1999.0123_RF71","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0140-6736(96)91133-2","article-title":"Red-cell antibodies in pregnancy: evidence overturned","volume":"347","author":"Clark","year":"1996","journal-title":"Lancet"},{"key":"10.1054\/blre.1999.0123_RF72","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1423-0410.1984.tb00093.x","article-title":"Prediction of the outcome of rhesus disease of the newborn: additional information using an ADCC assay","volume":"46","author":"Urbaniak","year":"1984","journal-title":"Vox Sang"},{"key":"10.1054\/blre.1999.0123_RF73","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1471-0528.1998.tb10059.x","article-title":"The ability of the chemiluminescence test to predict clinical outcome and the necessity for amniocenteses in pregnancies at risk of haemolytic disease of the newborn","volume":"105","author":"Hadley","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1054\/blre.1999.0123_RF74","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1046\/j.1469-0705.1998.11060432.x","article-title":"Prospective non-invasive monitoring of pregnancies complicated by red cell alloimmunization","volume":"11","author":"Iskaros","year":"1998","journal-title":"Ultrasound Obstet Gynaecol"},{"key":"10.1054\/blre.1999.0123_RF75","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200001063420102","article-title":"Noninvasive diagnosis by Doppler ultrasonography of fetal anemia dut to maternal red-cell alloimmunization","volume":"342","author":"Mari","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1054\/blre.1999.0123_RF76","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0002-9378(16)36265-2","article-title":"Liquor amnii analysis in management of pregnancy complicated by rhesus immunisation","volume":"82","author":"Liley","year":"1961","journal-title":"Am J Obstet Gynecol"},{"key":"10.1054\/blre.1999.0123_RF77","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/S0002-9378(11)90767-4","article-title":"Deviation in amniotic fluid optical density at a wavelength of 450 nm in Rh-immunized pregnancies from 14 to 40 weeks gestation: a proposal for clinical management","volume":"168","author":"Queenan","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1054\/blre.1999.0123_RF78","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/0002-9378(70)90099-2","article-title":"A three year assessment of an Action Line method of timing intervention in rhesus isoimmunisation","volume":"108","author":"Whitfield","year":"1970","journal-title":"Am J Obstet Gynecol"},{"key":"10.1054\/blre.1999.0123_RF79","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1056\/NEJM199308263290903","article-title":"Prenatal determination of fetal RhD type by DNA amplification","volume":"329","author":"Bennett","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1054\/blre.1999.0123_RF80","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJM199403173301122","article-title":"Prenatal determination of fetal RhD type","volume":"330","author":"Simsek","year":"1994","journal-title":"N Engl J Med,"},{"key":"10.1054\/blre.1999.0123_RF81","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1182\/blood.V85.10.2975.bloodjournal85102975","article-title":"Rapid RhD genotyping by polymerase chain reaction-based amplification of DNA","volume":"85","author":"Simsek","year":"1995","journal-title":"Blood"},{"key":"10.1054\/blre.1999.0123_RF82","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1046\/j.1537-2995.1997.371098016439.x","article-title":"RhD\/CE typing by polymerase chain reaction using sequence-specific primers","volume":"37","author":"Gussner","year":"1997","journal-title":"Transfusion"},{"key":"10.1054\/blre.1999.0123_RF83","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1046\/j.1537-2995.1996.36696269506.x","article-title":"Genotyping of KEL1 and KEL2 of the human Kell blood group system by PCR-SSP","volume":"36","author":"Hessner","year":"1996","journal-title":"Transfusion"},{"key":"10.1054\/blre.1999.0123_RF84","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/0002-9378(95)91349-1","article-title":"Accuracy of prenatal determination of RhD type status by polymerase chain reaction with amniotic cells","volume":"173","author":"Lighten","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"10.1054\/blre.1999.0123_RF85","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1182\/blood.V89.7.2568","article-title":"Evidence of genetic diversity underlying RhD-, weak D (Du), and partial D phenotypes as determined by multiplex polymerase chain analysis of the RHD gene","volume":"89","author":"Avent","year":"1997","journal-title":"Blood"},{"key":"10.1054\/blre.1999.0123_RF86","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1172\/JCI119543","article-title":"The RHD gene is highly detectable in RHD-negative Japanese donors","volume":"100","author":"Okuda","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1054\/blre.1999.0123_RF87","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0002-9378(99)70228-0","article-title":"Reliability and clinical application of fetal genotyping with two different fluorescent duplex polymerase chain reaction assays: three years\u2019 experience","volume":"180","author":"Crombach","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1054\/blre.1999.0123_RF88","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0887-7963(99)80056-X","article-title":"The rhesus blood group system: Insights from recent advances in molecular biology","volume":"13","author":"Avent","year":"1999","journal-title":"Trans Med Revs"},{"key":"10.1054\/blre.1999.0123_RF89","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1046\/j.1537-2995.1998.38111299056309.x","article-title":"Genotyping of RHD by multiplex polymerase chain reaction analysis of six RHD\u2013 specific exons","volume":"38","author":"Maaskant-van Wijk","year":"1998","journal-title":"Transfusion"},{"key":"10.1054\/blre.1999.0123_RF90","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1046\/j.1365-3148.1998.00173.x","article-title":"Rh phenotyping prediction by DNA typing and its application to practice","volume":"8","author":"Flegel","year":"1998","journal-title":"Transfus Med"},{"key":"10.1054\/blre.1999.0123_RF91","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1136\/bmj.2.5962.57","article-title":"Mechanisms of Rh prophylaxis: An experimental study on specificity of immunosuppression","volume":"2","author":"Woodrow","year":"1975","journal-title":"BMJ"},{"key":"10.1054\/blre.1999.0123_RF92","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1073\/pnas.96.5.2244","article-title":"Efficient IgG-mediated suppression of primary antibody responses in Fc-gamma receptor-deficient mice","volume":"96, 5","author":"Karlsson","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1054\/blre.1999.0123_RF93","first-page":"137","volume":"31","year":"1991","journal-title":"Prescribers\u2019 Journal"},{"key":"10.1054\/blre.1999.0123_RF94","series-title":"Memorandum on haemolytic disease of the newborn, 1976 \u2013 addendum 1981","year":"1982"},{"key":"10.1054\/blre.1999.0123_RF95","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1471-0528.1998.tb10285.x","article-title":"The prevention of Rh haemolytic disease of the fetus and newborn \u2013 General Background","volume":"105","author":"Contreras","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1054\/blre.1999.0123_RF96","first-page":"105; 129","article-title":"Anti-D immunoglobulin in RhD prophylaxis. Commentaries","author":"Robson","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1054\/blre.1999.0123_RF97","unstructured":"Tovey, L. A. D. Haemolytic Disease of the Newborn and its Prevention. Marcela, Contreras, ABC of Transfusion. BMJ Publishing Group, 1992, 22, 25"},{"key":"10.1054\/blre.1999.0123_RF98","series-title":"Haemolytic Disease of the Newborn","year":"1976"},{"key":"10.1054\/blre.1999.0123_RF99","first-page":"623","article-title":"Rh isoimmunisation during pregnancy: antenatal prophylaxis","volume":"118","author":"Bowman","year":"1978","journal-title":"Can Med Assoc J"},{"key":"10.1054\/blre.1999.0123_RF100","first-page":"627","article-title":"Antenatal prophylaxis of Rh isoimmunisation: 28 week-gestation service program","volume":"118","author":"Bowman","year":"1978","journal-title":"Can Med Assoc J."},{"key":"10.1054\/blre.1999.0123_RF101","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0140-6736(83)90232-5","article-title":"The Yorkshire antenatal anti-D immunoglobulin trial in primigravidae","volume":"ii","author":"Tovey","year":"1983","journal-title":"Lancet"},{"key":"10.1054\/blre.1999.0123_RF102","first-page":"4","article-title":"Antenatal prophylaxis of Rh immunisation with 250 mcg of anti-D immunoglobulin","volume":"124","author":"Herman","year":"1984","journal-title":"Acta Obstet Gynecol Scand (suppl),"},{"key":"10.1054\/blre.1999.0123_RF103","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0887-7963(87)70010-8","article-title":"Failures of intravenous Rh immune globulin prophylaxis: an analysis of the reasons for such failures","volume":"1","author":"Bowman","year":"1987","journal-title":"Transfus Med Rev"},{"key":"10.1054\/blre.1999.0123_RF104","first-page":"101","article-title":"The antepartum use of anti-D immunoglobulin in rhesus negative women. Parallel evaluation of fetal blood cells passing through the placenta. The results of a multicentre study carried out in the region of Paris","volume":"16","author":"Huchet","year":"1987","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"key":"10.1054\/blre.1999.0123_RF105","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3109\/00016348909087688","article-title":"Prenatal Rh-immune globulin prophylaxis with 300 mcg immune globulin anti-D in the 28th week of pregnancy","volume":"68","author":"Trolle","year":"1989","journal-title":"Acta Obstet Gynecol Scand."},{"key":"10.1054\/blre.1999.0123_RF106","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1136\/bmj.298.6689.1671","article-title":"Efficacy and long term effects of antenatal prophylaxis with anti-D immunoglobulin","volume":"298","author":"Thornton","year":"1989","journal-title":"BMJ"},{"key":"10.1054\/blre.1999.0123_RF107","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-3148.1995.tb00180.x","article-title":"Multicentre trial of antepartum low dose anti-D immunoglobulin","volume":"5","author":"Lee","year":"1995","journal-title":"Transfus Med"},{"key":"10.1054\/blre.1999.0123_RF108","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1471-0528.1998.tb10286.x","article-title":"The Scientific Basis of Antenatal Prophylaxis","volume":"105","author":"Urbaniak","year":"1998","journal-title":"Br J Obstet Gynaecol,"},{"key":"10.1054\/blre.1999.0123_RF109","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/(SICI)1099-1050(199607)5:4<319::AID-HEC211>3.0.CO;2-6","article-title":"An economic evaluation of antenatal anti-D prophylaxis in Scotland","volume":"5","author":"Vick","year":"1996","journal-title":"Health Economics"},{"key":"10.1054\/blre.1999.0123_RF110","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1471-0528.1998.tb10287.x","article-title":"Economics of Antenatal Prophylaxis","volume":"105","author":"Cairns","year":"1998","journal-title":"Br J Obstet Gynaecol."},{"key":"10.1054\/blre.1999.0123_RF111","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1046\/j.1537-2995.1999.39111160.x","article-title":"The epidemiology of virus transmission by plasma derivatives: clinical studies verifying lack of transmission of hepatitis B and C viruses and HIV type 1","volume":"39","author":"Tabor","year":"1999","journal-title":"Transfusion"},{"key":"10.1054\/blre.1999.0123_RF112","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0140-6736(95)92251-2","article-title":"Molecular epidemiology of an outbreak of infection with hepatitis C virus in recipients of anti-D immunoglobulin","volume":"346","author":"Power","year":"1995","journal-title":"Lancet"},{"key":"10.1054\/blre.1999.0123_RF113","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0268-960X(98)90007-8","article-title":"New-variant Creutzfeldt-Jacob disease: the risk of transmission by blood transfusion","volume":"12","author":"Turner","year":"1998","journal-title":"Blood Revs"},{"key":"10.1054\/blre.1999.0123_RF114","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0002-9378(98)70274-1","article-title":"Detection of fetal messenger ribonuceic acid in maternal blood to determine fetal RhD status as a strategy for noninvasive prenatal diagnosis","volume":"179","author":"Al-Mufti","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1054\/blre.1999.0123_RF115","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1056\/NEJM199812103392402","article-title":"Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma","volume":"339","author":"Lo","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1054\/blre.1999.0123_RF116","series-title":"Blood Transfusion: The Impact of new Technologies. Bailliere Clinical Haematology Series,","first-page":"243","article-title":"Production and characterisation of monoclonal anti-Rh","author":"Thompson","year":"1990"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X99901236?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X99901236?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,22]],"date-time":"2023-04-22T05:41:14Z","timestamp":1682142074000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X99901236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,3]]},"references-count":116,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,3]]}},"alternative-id":["S0268960X99901236"],"URL":"https:\/\/doi.org\/10.1054\/blre.1999.0123","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2000,3]]}}}